184 related articles for article (PubMed ID: 17382166)
1. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine.
Taha MA; Shokeir AA; Osman HG; Abd el-Aziz Ael-A; Farahat SE
Urology; 2007 Mar; 69(3):560-4; discussion 564-5. PubMed ID: 17382166
[TBL] [Abstract][Full Text] [Related]
2. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624
[TBL] [Abstract][Full Text] [Related]
3. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
BJU Int; 2007 Apr; 99(4):899-903. PubMed ID: 17378848
[TBL] [Abstract][Full Text] [Related]
4. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
Kajbafzadeh AM; Elmi A; Talab SS; Emami H; Esfahani SA; Saeedi P
J Urol; 2010 Jun; 183(6):2353-60. PubMed ID: 20400153
[TBL] [Abstract][Full Text] [Related]
5. Role of urinary tubular enzymes in evaluation of children with ureteropelvic junction narrowing under conservative management.
Shokeir AA; Taha MA
Urology; 2009 May; 73(5):1016-20. PubMed ID: 19394498
[TBL] [Abstract][Full Text] [Related]
6. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY
Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
[TBL] [Abstract][Full Text] [Related]
7. Ureteropelvic junction obstruction in children with renal ectopy.
Kramer SA; Kelalis PP
J Urol (Paris); 1984; 90(5):331-6. PubMed ID: 6501910
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction.
Parekh AD; Thomas JC; Trusler L; Ankerst DP; Deshpande JK; Adams MC; Pope JC; Brock JW
J Urol; 2008 Nov; 180(5):2171-5; discussion 2175-6. PubMed ID: 18804796
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrent ureteropelvic junction obstruction after open pyeloplasty in a large pediatric cohort.
Braga LH; Lorenzo AJ; Bägli DJ; Keays M; Farhat WA; Khoury AE; Salle JL
J Urol; 2008 Oct; 180(4 Suppl):1684-7; discussion 1687-8. PubMed ID: 18708226
[TBL] [Abstract][Full Text] [Related]
10. Vesicoureteral reflux and ureteropelvic junction obstruction in children with horseshoe kidney: treatment and outcome.
Cascio S; Sweeney B; Granata C; Piaggio G; Jasonni V; Puri P
J Urol; 2002 Jun; 167(6):2566-8. PubMed ID: 11992090
[TBL] [Abstract][Full Text] [Related]
11. Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function.
Shokeir AA; El-Sherbiny MT; Gad HM; Dawaba M; Hafez AT; Taha MA; Saida M; Ghaly AM
Urology; 2005 May; 65(5):980-5; discussion 985. PubMed ID: 15882736
[TBL] [Abstract][Full Text] [Related]
12. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.
Decramer S; Wittke S; Mischak H; Zürbig P; Walden M; Bouissou F; Bascands JL; Schanstra JP
Nat Med; 2006 Apr; 12(4):398-400. PubMed ID: 16550189
[TBL] [Abstract][Full Text] [Related]
13. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.
Atar A; Oktar T; Kucukgergin C; Kalelioglu I; Seckin S; Ander H; Ziylan O; Kadioglu TC
J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction in children.
Kojima Y; Sasaki S; Mizuno K; Tozawa K; Hayashi Y; Kohri K
Int J Urol; 2009 May; 16(5):472-6. PubMed ID: 19383038
[TBL] [Abstract][Full Text] [Related]
15. [Lower pole pedicle in a series of 84 pyelo-ureteral junction syndromes surgically treated in children].
Lopez C; A'ch S; Veyrac C; Morin D; Averous M
Prog Urol; 2000 Sep; 10(4):638-43. PubMed ID: 11064915
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic pyeloplasty in children: Is the outcome different in children under 2 years of age?
Vicentini FC; Dénes FT; Borges LL; Silva FA; Machado MG; Srougi M
J Pediatr Urol; 2008 Oct; 4(5):348-51. PubMed ID: 18790418
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of congenital ureteropelvic junction obstruction: a Pediatric Health Information System database study.
Vemulakonda VM; Cowan CA; Lendvay TS; Joyner BD; Grady RW
J Urol; 2008 Oct; 180(4 Suppl):1689-92; discussion 1692. PubMed ID: 18708209
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneoscopic vs open dismembered pyeloplasty for ureteropelvic junction obstruction in children.
Valla JS; Breaud J; Griffin SJ; Sautot-Vial N; Beretta F; Guana R; Gelas T; Carpentier X; Leculee R; Steyaert H
J Pediatr Urol; 2009 Oct; 5(5):368-73. PubMed ID: 19369118
[TBL] [Abstract][Full Text] [Related]
19. Which is better--retroperitoneoscopic or laparoscopic dismembered pyeloplasty in children?
Canon SJ; Jayanthi VR; Lowe GJ
J Urol; 2007 Oct; 178(4 Pt 2):1791-5; discussion 1795. PubMed ID: 17707427
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
